Dual Targeting of the Epidermal Growth Factor Receptor Using the Combination of Cetuximab and Erlotinib: Preclinical Evaluation and Results of the Phase II DUX Study in Chemotherapy-Refractory, Advanced Colorectal Cancer
WEICKHARDT, Andrew J, PRICE, Tim J, SALEMI, Renato, SCOTT, Andrew M, MARIADASON, John M, TEBBUTT, Niall C, CHONG, Geoff, GEBSKI, Val, PAVLAKIS, Nick, JOHNS, Terrance G, AZAD, Arun, SKRINOS, Effie, FLUCK, Kate, DOBROVIC, Alexander
Published in Journal of clinical oncology (01.05.2012)
Published in Journal of clinical oncology (01.05.2012)
Get full text
Journal Article
Abstract CT101: Phase I safety and bioimaging trial of ifabotuzumab in patients with glioblastoma
Gan, Hui K., Cher, Lawrence, Inglis, Po, Lwin, Zarnie, Lau, Eddie, Wichmann, Christian, McDonald, Alex, Gunjur, Ashray, Ackermann, Uwe, Remen, Kirsten, Fluck, Kate, Bolarnos, Gel, Guo, Nancy, Lee, Sze Ting, Gong, Sylvia, Palmer, Jodie B., Pathmaraj, Kunthi, O'Keefe, Graeme J., Scott, Fiona E., Day, Bryan W., Boyd, Andrew W., Thomas, Paul, Ahmed, Omar, Chappell, Dale, Durrant, Cameron, Scott, Andrew M.
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article